What type of drug is Emgality?
Medically reviewed by Drugs.com Last updated on Jun 5, 2019.
Official Answerby Drugs.com
When CGRP binds to its receptor, a cascade of events such as vasodilation and protein leakage begin that results in inflammation and pain associated with migraine.
Emgality from Eli Lilly is the third drug approved in this class of drugs, joining previously approved CGRP antagonists Ajovy (fremanezumab-vfrm) from Teva Pharmaceutical and Aimovig (erenumab-aooe) from Amgen.
How do calcitonin gene-related peptide (CGRP) antagonists work?
- Emgality and Ajovy work similarly: they bind to the CGRP ligand and block its binding to the receptor to help prevent migraine pain.
- Aimovig selectively binds to the CGRP receptor (not the ligand) to block CGRP activation, thereby preventing migraine pain.
Related Medical Questions
- What type of drug is Ajovy?
- What is the cost of the migraine drug Ajovy?
- What are the new drugs for the treatment and prevention of migraine?
- How do you use Onzetra Xsail?
- Dysport vs Botox: What's the difference?
- How does Aimovig work to prevent migraine?
- What are the side effects of beta blockers?